Synthetic Biology Market Summary
As per MRFR Analysis, the Synthetic Biology Market was valued at 10.25 USD Billion in 2023 and is projected to grow to 40.2 USD Billion by 2035, with a CAGR of 12.06% from 2025 to 2035. The market is driven by advancements in technology, increasing demand for sustainable solutions, and significant government support.
Key Market Trends & Highlights
Key trends driving the Synthetic Biology Market include technological advancements and a focus on sustainability.
- Healthcare Application is expected to grow from 4.15 USD Billion in 2024 to 14.7 USD Billion by 2035.
- Industrial Biotechnology is projected to increase from 2.8 USD Billion in 2024 to 9.8 USD Billion by 2035.
- The Agricultural sector is anticipated to rise from 2.3 USD Billion in 2024 to 8.1 USD Billion by 2035.
- North America is expected to dominate the market with a valuation of 5.36 USD Billion in 2024.
Market Size & Forecast
2023 Market Size: USD 10.25 Billion
2024 Market Size: USD 11.49 Billion
2035 Market Size: USD 40.2 Billion
CAGR (2025-2035): 12.06%
Largest Regional Market Share in 2024: North America.
Major Players
Key players include Tessera Therapeutics, DuPont, Novozymes, Ginkgo Bioworks, Thermo Fisher Scientific, Integrated DNA Technologies, Synlogic, Berkeley Lights, Codexis, Corteva Agriscience, Arzeda, Genomatica, Zymergen, and Amgen.
Key Synthetic Biology Market Trends Highlighted
Technology breakthroughs and increased knowledge of bioengineering applications are driving a number of noteworthy trends in the Synthetic Biology Market. The growing need for sustainable solutions in a variety of sectors, including environmental management, healthcare, and agriculture, is one of the major market drivers.
Global worries about food security, climate change, and the demand for cutting-edge medical treatments are the main causes of this increase. Furthermore, substantial R&D expenditures from the public and commercial sectors are promoting advancements in synthetic biology and creating a competitive atmosphere that pushes limits and brings new goods and services to the market.
Stakeholders in synthetic biology have several opportunities, especially in personalized medicine, where customized treatments can improve patient outcomes. Investment in the application of modified organisms for biofuel generation and bioremediation is appealing because it presents an opportunity to address environmental issues.Furthermore, the incorporation of artificial intelligence into synthetic biology procedures is opening up possibilities for design optimization and efficiency gains, which have the potential to further transform biological system-dependent enterprises.
Collaborative research projects between academic institutions, biotech companies, and governmental agencies have increased recently with the goal of expediting synthetic biology applications for the benefit of society. This pattern indicates a wider understanding of synthetic biology's ability to address global problems including disease outbreaks and ecological degradation.The industry benefits from a supportive environment created by rules that are evolving to enable scientific discovery while preserving safety, which is anticipated to lead to greater worldwide expansion and implementation of synthetic biology solutions.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Synthetic Biology Market Drivers
Growing Demand for Sustainable Production Methods
The Synthetic Biology Market is witnessing significant growth due to the increasing demand for sustainable production processes across various sectors. Governments around the world are implementing regulations to reduce carbon emissions and promote green technologies.
For instance, as per the United Nations Environment Programme, global greenhouse gas emissions are projected to rise by 16% from 1990 to 2030 if no action is taken. This has led major corporations to invest in synthetic biology, aiming to produce biofuels, biodegradable plastics, and other sustainable materials.
Companies like Bayer and DuPont are at the forefront of these innovations, developing engineered microorganisms to minimize environmental impact. Their investments reflect a growing industry shift towards utilizing synthetic biology to create eco-friendly products, indicating that the market could expand as lawmakers impose stricter environmental guidelines and consumers favor sustainable options.
Advancements in Genetic Engineering
The continuous advancements in genetic engineering technologies have been a significant driver for the Synthetic Biology Market. Breakthroughs in genome editing technologies, such as CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats), have enabled more precise modifications at a much lower cost.
The National Institutes of Health states that the CRISPR market size is expected to reach over USD 6 billion by 2025 due to its extensive applications in agriculture, pharmaceuticals, and biotechnology.This has opened new avenues for synthetic biology applications, making it possible to engineer organisms with tailored functionalities. Leading biotech firms are leveraging these advancements to accelerate their research and development, thus propelling market growth as new solutions become commercially viable.
Increased Funding for Research and Development
Rising investments in Research and Development (R&D) specific to synthetic biology are substantially contributing to the market's growth. According to government data, global investments in biotechnology R&D have tripled over the past decade, reaching approximately USD 150 billion in 2021, with synthetic biology accounting for a significant portion of this funding.
Major government initiatives, such as the U.S. National Bioeconomy Initiative, are designed to boost funding in life sciences and synthetic biology. This influx of capital allows companies to explore innovative solutions in areas such as healthcare, agricultural productivity, and bioengineering.As firms like Amgen and Genomatica leverage these funds to enhance their capabilities, they will likely drive overall market expansion and innovation in the Synthetic Biology Market.
Synthetic Biology Market Segment Insights
Synthetic Biology Market Application Insights
In the Synthetic Biology Market, the application segment exhibited notable growth and diversification across various industries. This segment played a crucial role in addressing both current challenges and opportunities within its diversified arenas.The healthcare sector, in particular, was a major driving force in this market, achieving a valuation of 3.2 USD Billion in 2024, which is expected to expand significantly to 11.6 USD Billion by 2035. This growth is largely attributed to the increasing focus on personalized medicine, biologics, and innovative treatments that harness synthetic biology for improved patient outcomes.
Following closely, the Industrial Biotechnology segment, valued at 2.8 USD Billion in 2024 and projected to grow to 9.5 USD Billion by 2035, illustrated the relevance of synthetic biology in developing sustainable products and processes, promoting green chemistry, and reducing waste, making it an essential player in industries facing environmental pressures.
Agriculture also displayed significant potential, with a valuation of 2.0 USD Billion in 2024 expected to rise to 7.5 USD Billion by 2035. The integration of synthetic biology in agriculture can lead to the development of genetically modified organisms that offer higher yields, pest resistance, and climate adaptability, essential for food security in a growing global population.Environmental Applications, valued at 1.5 USD Billion in 2024 and anticipated to increase to 5.2 USD Billion by 2035, harnessed synthetic biology for bioremediation and waste processing solutions, directly impacting ecological preservation and restoration efforts.
The Food and Nutrition sector also contributed to this market segment, valued at 2.0 USD Billion in 2024 with an expected rise to 6.3 USD Billion by 2035, highlighting the increasing incorporation of synthetic biology in food production and nutritional enhancement.The combined dynamics of these segments suggested a growing recognition of the transformative potential that synthetic biology held across various applications, underlining their importance in driving innovation and efficiency in the respective industries.
As these developments continue, the Synthetic Biology Market data revealed a landscape ripe with opportunities, driven by technological advancements and increased investment in Research and Development across healthcare, industrial, agricultural, environmental, and food sectors, lending to a promising outlook for market growth that reflects changing consumer demands and sustainability goals globally.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Synthetic Biology Market Technology Insights
The Technology segment of the Synthetic Biology Market is expected to play a significant role in shaping the industry's landscape. This segment encompasses various key areas, including Gene Synthesis, Gene Editing, Synthetic Genomics, Metabolic Engineering, and Cloning, each contributing uniquely to the overall market.Gene Synthesis is crucial for creating custom DNA sequences, enabling advancements in biotechnology and pharmaceuticals. Gene Editing technologies, such as CRISPR, are revolutionizing genetic modifications, offering precise and efficient solutions across numerous applications.
Synthetic Genomics allows for the reconstruction of entire genomes, which has implications for biofuel production and synthetic vaccines. Metabolic Engineering focuses on optimizing metabolic pathways for improved production yields in industrial biotechnology.Cloning remains significant for research and therapeutic purposes, facilitating the creation of genetically identical organisms for various studies. Together, these areas within the Technology segment drive innovation and growth in the Synthetic Biology Market, highlighting the importance of ongoing Research and Development efforts in this dynamic and fast-evolving field.
Synthetic Biology Market Product Type Insights
The Synthetic Biology Market is substantially driven by its diverse product type landscape, which comprises synthetic genes, enzymes, chassis organisms, nucleotides, and bioinformatics tools. Synthetic Genes play a crucial role in biomanufacturing processes, enabling the development of genetically modified organisms for various applications.Enzymes, essential for bio-catalysis, dominate in the biotechnology sector, influencing research and industrial processes with efficiency improvements. Additionally, Chassis Organisms serve as foundational platforms in synthetic biology, facilitating the engineering of complex biological systems.
Nucleotides serve critical roles in genetic constructions and applications in fields such as therapeutics and agricultural enhancement, while Bioinformatics Tools are increasingly vital for data analysis and management, creating a wealth of opportunities for innovation in the Synthetic Biology Market.Overall, the segmentation reflects the increasing significance of these components in research and commercial applications, aligned with global trends towards sustainability and personalized medicine.
Synthetic Biology Market End-use Industry Insights
The sector encompasses crucial applications, including Pharmaceuticals, Biochemicals, Crop Production, Biofuels, and Food and Beverage, each demonstrating significant growth and relevance. The Pharmaceuticals segment plays a pivotal role, leveraging synthetic biology for drug development and personalized medicine, driven by innovative processes and efficiency.Biochemicals are increasingly produced from sustainable sources, aligning with global trends toward eco-friendly production methods. Crop Production benefits from advanced genetic modifications, enhancing yield and resilience against climate change, offering food security on a global scale.
Biofuels are seen as a key solution to energy challenges, utilizing biological processes for cleaner alternatives to fossil fuels. Additionally, the Food and Beverage sector incorporates synthetic biology for improved nutrition and flavor profiles, catering to evolving consumer preferences.As these industries expand, they contribute substantially to the Synthetic Biology Market revenue, with market growth influenced by technology advances, regulatory support, and rising demand for sustainable solutions.
Synthetic Biology Market Regional Insights
The Synthetic Biology Market reached a significant valuation, highlighting the regional dynamics and growth potential within this sector. In 2024, North America led the market with a valuation of 4.6 USD Billion, expected to rise to 16.5 USD Billion by 2035, demonstrating a majority holding in the market due to its robust Research and Development activities and technological advancements.
Europe followed with a valuation of 3.2 USD Billion in 2024, increasing to 11.5 USD Billion by 2035, driven by strong regulatory frameworks and innovation in biotechnology.South America, while smaller, showed growth from 0.8 USD Billion in 2024 to 2.9 USD Billion by 2035, reflecting emerging opportunities in synthetic biology applications in agriculture and health. The Asia Pacific region, valued at 2.5 USD Billion in 2024, is projected to reach 9.0 USD Billion by 2035, underscoring its growing influence due to increasing investments and a favorable demographic profile.
Lastly, the Middle East and Africa, valued at 0.39 USD Billion in 2024, with a growth to 0.9 USD Billion by 2035, indicated a nascent yet developing market primarily influenced by increased focus on biotechnology solutions in healthcare and environmental sustainability.Each region's market growth reflected unique opportunities and challenges within the Synthetic Biology Market landscape, shaping industry strategies and innovations.
$IMAGE3_HERE$
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Synthetic Biology Market Key Players and Competitive Insights
The Synthetic Biology Market is experiencing significant growth driven by advancements in genetic engineering, biotechnology, and the increasing application of synthetic biology across various industries such as healthcare, agriculture, and environmental sustainability.Competitive insights within this market reveal an ecosystem characterized by rapid innovation, strategic collaborations, mergers, and acquisitions, as key players seek to strengthen their positions and expand their product offerings.
The competitive landscape is marked by a diverse range of stakeholders, including startups, established biotechnology firms, and large pharmaceutical companies, each striving to leverage synthetic biology technologies to develop solutions that address pressing global challenges.This dynamic environment demands a keen understanding of market trends, technological advancements, and regulatory changes, shaping the strategies of companies aiming to lead in the synthetic biology arena.
Ginkgo Bioworks stands out in the Synthetic Biology Market with a robust portfolio and a strong market presence, particularly in the field of organism engineering. The company leverages its unique platform for designing custom microbes that can perform specific functions, aligning closely with the needs of partners across various sectors including agriculture, pharmaceuticals, and materials.Ginkgo Bioworks' strengths lie in its proprietary technologies, extensive expertise in biology, and an innovative approach that emphasizes scalability and efficiency.
The company has successfully established itself as a leader in synthetic biology by focusing on collaborations with a wide range of clients and investing in research and development to enhance its offerings, making it a pivotal player in shaping the future of synthetic biology on a global scale.Regeneron Pharmaceuticals, while primarily recognized for its biopharmaceutical developments, has made significant inroads into the Synthetic Biology Market through its innovative drug discovery technologies and commitment to harnessing biological systems for therapeutic developments.
The company’s key products include monoclonal antibodies and gene therapies, which exemplify its capability to integrate synthetic biology principles into its research processes. Regeneron Pharmaceuticals boasts a strong market presence fueled by its continuous investment in research and clinical trials that push the boundaries of synthetic biology applications in medicine.
The company’s strengths lie in its advanced technological capabilities, strategic partnerships, and a robust portfolio that addresses unmet medical needs. Additionally, recent mergers and acquisitions have enhanced its capabilities in synthetic biology, allowing it to further expand its reach and integrate new technologies, solidifying its position as a formidable player in the global synthetic biology landscape.
Key Companies in the Synthetic Biology Market Include
- Ginkgo Bioworks
- Regeneron Pharmaceuticals
- DuPont
- Corteva
- Amyris
- Twist Bioscience
- Synlogic
- Genomatica
- Codexis
- Synthetic Genomics
- Arzeda
- Lonza
- Illumina
- Cynata Therapeutics
Synthetic Biology Market Developments
In the first-ever case of a customized CRISPR treatment for a single patient, Acuitas Therapeutics reported in April 2025 that it had successfully used its lipid nanoparticle (LNP) delivery platform to deliver a personalized CRISPR-based gene-editing therapy to a newborn with an extremely rare genetic disorder.In order to strengthen its synthetic biology skills by incorporating Verve Therapeutics' CRISPR-based PCSK9 gene therapy, which recently progressed from Phase I to Phase II studies aimed at cardiovascular illness.
Basecamp Research announced in June 2025 that its environmental DNA (eDNA) sequencing project had identified more than a million new microbial species. These findings were used to train artificial intelligence (AI) models that could create programmable large serine recombinases (LSRs), which could have implications for advanced oncology gene editing.
Constructive Bio, a spin-out from Cambridge University, received $58 million in financing in March 2025 to set up sustainable microbial manufacturing methods for new chemical molecules, including as antibody-drug conjugates and semaglutide precursors.Ginkgo Bioworks solidified its position as a leader in synthetic biology platforms in October 2024 by continuing to grow its "biofoundry" model by collaborating with significant industrial clients to create unique microorganisms for uses ranging from biodegradable materials to self-fertilizing crops.
Synthetic Biology Market Segmentation Insights
Synthetic Biology Market Application Outlook
- Healthcare
- Industrial Biotechnology
- Agriculture
- Environmental Applications
- Food and Nutrition
Synthetic Biology Market Technology Outlook
- Gene Synthesis
- Gene Editing
- Synthetic Genomics
- Metabolic Engineering
- Cloning
Synthetic Biology Market Product Type Outlook
- Synthetic Genes
- Enzymes
- Chassis Organisms
- Nucleotides
- Bioinformatics Tools
Synthetic Biology Market End-use Industry Outlook
- Pharmaceuticals
- Biochemicals
- Crop Production
- Biofuels
- Food and Beverage
Synthetic Biology Market Regional Outlook
- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa
|
Report Attribute/Metric
|
Details
|
|
Market Size 2023
|
10.25(USD Billion)
|
|
Market Size 2024
|
11.49(USD Billion)
|
|
Market Size 2035
|
40.2(USD Billion)
|
|
Compound Annual Growth Rate (CAGR)
|
12.06% (2025 - 2035)
|
|
Report Coverage
|
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
|
|
Base Year
|
2024
|
|
Market Forecast Period
|
2025 - 2035
|
|
Historical Data
|
2019 - 2024
|
|
Market Forecast Units
|
USD Billion
|
|
Key Companies Profiled
|
Ginkgo Bioworks, Regeneron Pharmaceuticals, DuPont, Corteva, Amyris, Twist Bioscience, Synlogic, Genomatica, Codexis, Synthetic Genomics, Arzeda, Lonza, Illumina, Cynata Therapeutics
|
|
Segments Covered
|
Application, Technology, Product Type, End-use Industry, Regional
|
|
Key Market Opportunities
|
Gene editing innovations, Sustainable biofuel production, Customizable biomanufacturing solutions, Healthcare applications advancement, Agricultural biotechnology enhancements
|
|
Key Market Dynamics
|
increased R&D investments, growing healthcare applications, advancements in genome editing, environmental sustainability initiatives, rising demand for biofuels
|
|
Countries Covered
|
North America, Europe, APAC, South America, MEA
|
Synthetic Biology Market Highlights:
Frequently Asked Questions (FAQ) :
The Synthetic Biology Market was valued at 11.49 USD Billion in 2024.
By 2035, the Synthetic Biology Market is projected to reach a value of 40.2 USD Billion.
The expected CAGR for the Synthetic Biology Market is 12.06% from 2025 to 2035.
North America is expected to dominate the Synthetic Biology Market with a valuation of 16.5 USD Billion by 2035.
The Healthcare application of Synthetic Biology is projected to be valued at 11.6 USD Billion by 2035.
Key players in the Synthetic Biology Market include Ginkgo Bioworks, Regeneron Pharmaceuticals, and DuPont, among others.
Industrial Biotechnology held a market size of 2.8 USD Billion in 2024.
The Synthetic Biology Market in the Asia Pacific region is projected to reach 9.0 USD Billion by 2035.
The Environmental Applications segment of the Synthetic Biology Market is expected to be valued at 5.2 USD Billion by 2035.
The Agriculture application segment is anticipated to grow to a valuation of 7.5 USD Billion by 2035.
